Xin-Yu Fan

Prof. Xin-Yu Fan


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2018 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
XFXin-Yu Fan
Xin-Yu Fan
JYJing‐Yu Yang
Jing‐Yu Yang
YDYing‐Xu Dong
Ying‐Xu Dong
YHYing Hou
Ying Hou
SLShuai Liu
Shuai Liu
CWChun-fu Wu
Chun-fu Wu

16 September 2022 in Neural Regeneration Research
Verified
Journal Article
Open access
GSGuang Shi
Guang Shi
JFJuan Feng
Juan Feng
LJLing-Yan Jian
Ling-Yan Jian
XFXin-Yu Fan
Xin-Yu Fan
JOURNAL/nrgr/04.03/01300535-202304000-00031/figure1/v/2026-05-25T155121Z/r/image-tiff Cerebral ischemia/reperfusion injury impairs learning and memory in patients. Studies have shown that synaptic function is involved in the formation and development of memory, and that DNA methylation plays a key role in the regulation of learning and memory. To investigate the role of DNA hypomethylation in cerebral ischemia/reperfusion injury, in this study, we established a rat model of cerebral ischemia/reperfusion injury by occlusion of the middle cerebral artery and then treated the rats with intraperitoneal 5-aza-2′-deoxycytidine, an inhibitor of DNA methylation. Our results showed that 5-aza-2′-deoxycytidine markedly improved the neurological function, and cognitive, social and spatial memory abilities, and dose-dependently increased the synaptic density and the expression of SYP and SHANK2 proteins in the hippocampus in a dose-dependent manner in rats with cerebral ischemia/reperfusion injury. The effects of 5-aza-2′-deoxycytidine were closely related to its reduction of genomic DNA methylation and DNA methylation at specific sites of the Syp and Shank2 genes in rats with cerebral ischemia/reperfusion injury. These findings suggest that inhibition of DNA methylation by 5-aza-2′-deoxycytidine promotes the recovery of learning and memory impairment in a rat model of cerebral ischemia/reperfusion injury. These results provide theoretical evidence for stroke treatment using epigenetic methods.

31 August 2024 in Phytomedicine
Verified
Journal Article
Closed access
LZLei Zhao
Lei Zhao
HMHeyao Ma
Heyao Ma
YJYuhui Jiang
Yuhui Jiang
YLYingying Li
Yingying Li
NGNing Guo
Ning Guo
XFXin-Yu Fan
Xin-Yu Fan

24 July 2024 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
TLTian‐Cong Liu
Tian‐Cong Liu
HLHong‐Xi Li
Hong‐Xi Li
YWYu‐Xiao Wan
Yu‐Xiao Wan
GSGuang Shi
Guang Shi
YZYun‐Peng Zhao
Yun‐Peng Zhao
XFXin-Yu Fan
Xin-Yu Fan
N6‐methyladenosine (m6A) methylation is a vital epigenetic mechanism associated with drug addiction. However, the relationship between m6A modification and oxycodone rewarding is less well explored. Based on an open field test, the present study evaluated oxycodone rewarding using chromatin immunoprecipitation PCR, immunofluorescence, and RNA sequencing. A marked increase in METTL14 protein and a decrease in PP1α protein due to oxycodone abundance in the striatal neurons were observed in a dose‐ and time‐dependent manner. Oxycodone markedly increased LSD1 expression, and decreased H3K4me1 expression in the striatum. In the open field test, intra‐striatal injection of METTL14 siRNA, HOTAIR siRNA, or LSD1 shRNA blocked oxycodone‐induced increase in locomotor activity. The downregulation of PP1α was also inhibited after treatment with METTL14/HOTAIR siRNA and LSD1 shRNA. Enhanced binding of LSD1 with CoRest and of CoRest with the PP1α gene induced by oxycodone was also reversed by LSD1 shRNA. In addition, H3K4me1 demethylation was also blocked by the treatment. In summary, the investigation confirmed that METTL14‐mediated upregulation of HOTAIR resulted in the repression of PP1α, which in turn facilitated the recruitment of LSD1, thus catalyzing H3K4me1 demethylation and promoting oxycodone addiction.

25 November 2022 in Addiction Biology
Verified
Journal Article
Closed access
YWYu‐Xiao Wan
Yu‐Xiao Wan
GSGuang Shi
Guang Shi
LJLing‐Yan Jian
Ling‐Yan Jian
XFXin-Yu Fan
Xin-Yu Fan

1 September 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
SLShuai Liu
Shuai Liu
SXShuohan Xu
Shuohan Xu
HLHang Lu
Hang Lu
XGXueyu Gong
Xueyu Gong
HLHuaipeng Li
Huaipeng Li
HYHongwei Yang
Hongwei Yang
The primary aim of this study was to fabricate a wound healing thermosensitive in situ gel containing Periplaneta americana extract (PAE), which is widely utilized clinically due to its anti-inflammatory and skin regeneration effects. The thermosensitive in situ gel was prepared using F127 and F68 at concentrations of 17.5% (w/v) and 3.75% (w/v) respectively. The physicochemical properties of the PAE-loaded gel was characterized by DSC, scanning electron microscopy, and FTIR. Additionally, the in vitro release behavior and the in vivo wound healing effects were also investigated. It was observed that the thermosensitive in situ gel exhibited a sol-gel transition temperature of approximately 32.5 °C ± 0.4 °C, and the PAE existed in an amorphous state within the lyophilized gel. FTIR spectra indicated the formation of hydrogel bonds between PAE and F127/F68, signifying a sustained release profile. Further in vivo wound healing and inflammatory cytokine experiments revealed that the drug-loaded hydrogel demonstrated superior wound healing activity compared to other counterparts, by accelerating the reduction of endogenous inflammatory mediators such as TNF-α, MMP9, and IL-6, and inhibiting the MAPK/NF-κB pathway. The PAE-loaded thermosensitive in situ gel represents a promising pharmaceutical candidate for local wound healing applications, owing to its prolonged retention time.